Angiotensin Converting Enzyme 2 (ACE2)
Showing 1 - 25 of >10,000
Angiotensin-converting Enzyme 2 Expression in Tonsils and
Withdrawn
- Adenoidectomy
- Tonsillectomy
- Storage of operating waste
-
Créteil, France
- +8 more
Jul 5, 2021
Angiotensin Converting Enzyme, Brain, Gut Dysbiosis in Pulmonary
Active, not recruiting
- Pulmonary Arterial Hypertension
-
Jacksonville, Florida
- +1 more
Jan 10, 2022
Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)
Completed
- Type 2 Diabetes Mellitus
- Hypertension
- Placebo
- +3 more
-
Nashville, TennesseeVanderbilt University
Feb 8, 2022
Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)
Not yet recruiting
- Diabetic Nephropathy Type 2
- Empagliflozin 25 MG
- Enalapril Maleate 20 mg
- (no location specified)
May 9, 2022
Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal
Recruiting
- Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
- High ACE Activity Fresh Frozen Plasma
- Normal Saline
-
Saint Louis, MissouriBarnes-Jewish Hospital
Oct 24, 2022
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Vitamin K 2
- (no location specified)
Jul 4, 2023
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Coronavirus Disease 2019 Patients Receiving Receiving
Completed
- COVID-19
- Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Centre
Aug 1, 2020
Hydrochlorothiazide and Risk of Skin Cancer
Completed
- Non-melanoma Skin Cancer
- +2 more
- Hydrochlorothiazide
- Angiotensin-converting enzyme (ACE) inhibitors
-
Montreal, Quebec, CanadaCentre for Clinical Epidemiology, Lady Davis Institute, Jewish G
Mar 8, 2021
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Covid19 Trial in Vienna (Angiotensin Converting Enzyme 2, Sodium chloride)
Completed
- Covid19
- Angiotensin Converting Enzyme 2
- Sodium chloride
-
Vienna, AustriaMedical University of Vienna
Sep 22, 2022
Oral Lesions, COVID-19, Angiotensin-converting Enzyme 2 Trial in Kafr Ash Shaykh (detection of oral lesions)
Completed
- Oral Lesions
- +2 more
- detection of oral lesions
-
Kafr Ash Shaykh, Kafr El-sheikh, EgyptDalia Rasheed Issa
Apr 1, 2022
Abdominal Aortic Aneurysm Trial in United Kingdom (perindopril arginine, amlodipine 5mgs, )
Completed
- Abdominal Aortic Aneurysm
- perindopril arginine
- +2 more
-
Bournemouth, United Kingdom
- +8 more
Jan 5, 2021
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023
COVID-19 Trial (Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2))
Not yet recruiting
- COVID-19
- Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2)
- (no location specified)
Jun 5, 2021
Covid-19 Trial in Hellerup, Herlev (Discontinuation of ACEi/ARB, Continuation of ACEi/ARB)
Completed
- Covid-19
- Discontinuation of ACEi/ARB
- Continuation of ACEi/ARB
-
Hellerup, Capital Region Of Denmark, Denmark
- +1 more
Jan 17, 2023
COVID Trial (Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid)
Not yet recruiting
- COVID
- Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid
- (no location specified)
Jun 5, 2021
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023
Diabetic Kidney Disease Trial in Australia (SER150, Placebo)
Recruiting
- Diabetic Kidney Disease
- SER150
- Placebo
-
Liverpool, New South Wales, Australia
- +6 more
May 17, 2022
Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)
Recruiting
- Heart Failure
- Sacubitril Valsartan Sodium Hydrate
- Standard treatment
-
Saga, JapanSaga University Hospital
Dec 27, 2021
Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)
Recruiting
- Chagas Cardiomyopathy
- Sacubitril / Valsartan Oral Tablet [Entresto]
- Enalapril
-
São Paulo, BrazilHeart Institute (Incor) University of Sao Paulo
May 6, 2021
Myocardial Infarction With Non-obstructive Coronary Arteries Trial in Worldwide (Beta blocker, ACEI, ARB)
Recruiting
- Myocardial Infarction With Non-obstructive Coronary Arteries
- Beta blocker
- +2 more
-
Adelaide, Sout Australi, Australia
- +19 more
Sep 6, 2021